Diagnosis and Treatment of Diseases of Lipid and Lipoprotein Metabolism in Adults and Children

BACKGROUND
1 Introduction to Lipids and Lipoproteins	Kenneth R. Feingold, MD
2 Utility of Advanced Lipoprotein Testing in Clinical Practice	Kenneth R. Feingold, MD
3 The Role of Lipids and Lipoproteins in Atherosclerosis	MacRae F. Linton, MD, Patricia G. Yancey, PhD, Sean S. Davies, PhD, W. Gray (Jay) Jerome, PhD, Edward F. Linton, BA, Wenliang L. Song, MD, Amanda C. Doran, PhD, MD and Kasey C. Vickers, PhD
4 Guidelines for the Management of High Blood Cholesterol	Kenneth R. Feingold, MD
5 Risk of Fasting and Non-Fasting Hypertriglyceridemia in Coronary Vascular Disease and Pancreatitis	Andrew Messersmith, MD, MPH, Rahul Purbey, MD and Lisa R. Tannock, MD
GENETIC DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM
6 Familial Hypercholesterolemia: Genes and Beyond	Bruce A. Warden PharmD, BCPS-AQ Cardiology, CLS, FNLA, FASPC, Sergio Fazio MD, PhD and Michael D. Shapiro, DO, MCR
7 Hypertriglyceridemia: Pathophysiology, Role of Genetics, Consequences, and Treatment	Savitha Subramanian, MD
8 Dysbetalipoproteinemia (Type III Hyperlipoproteinemia)	Weerapan Khovidhunkit, MD, PhD
9 Lysosomal Acid Lipase Deficiency	Don P. Wilson, MD, FNLA and Nivedita Patni, MD
10 Sitosterolemia	Ann Liebeskind, MD, Amy L. Peterson, MD, MS and Don P. Wilson, MD, FNLA
11 Cerebrotendinous Xanthomatosis	Nivedita Patni, MD and Don P. Wilson, MD, FNLA
12 Lipoprotein (a)	Weerapan Khovidhunkit, MD, PhD
13 Monogenic Disorders Causing Hypobetalipoproteinemia	Michael D. Shapiro, DO, MCR and Kenneth R. Feingold, MD
14 Monogenic Disorders Altering HDL Levels	Michael D. Shapiro, DO, MCR and Kenneth R. Feingold, MD
15 Lipodystrophy Syndromes: Presentation and Treatment	Baris Akinci, Merve Celik Guler and Elif A. Oral
SECONDARY DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM AND SPECIAL POPULATIONS
16 Dyslipidemia in Patients With Diabetes	Kenneth R. Feingold, MD
17 Dyslipidemia in Chronic Kidney Disease	Steven Lacount, DO and Lisa R. Tannock, MD
18 Lipid and Lipoprotein Metabolism in Liver Disease	David E. Cohen MD, PhD and Kathleen E. Corey MD MPH, MMSc
19 The Effect of Endocrine Disorders on Lipids and Lipoproteins	Kenneth R. Feingold, MD
20 The Effect of Inflammation and Infection on Lipids and Lipoproteins	Kenneth R. Feingold, MD and Carl Grunfeld, MD, PhD
21 Lipid Disorders In People With HIV	Sudipa Sarkar, MD, MSCI and Todd T. Brown MD, PhD
22 Lipid and Lipoprotein Levels in Patients with Covid-19 Infections	Kenneth R. Feingold, MD
23 Medication Induced Changes in Lipid and Lipoproteins	Megan Herink, Pharm.D., BCPS and Matthew K. Ito, Pharm.D., FCCP, FNLA, CLS.
24 Obesity and Dyslipidemia	Kenneth R. Feingold, MD
25 Evaluation and Treatment of Dyslipidemia in the Elderly	Elani Streja, Ph.D. and Kenneth R. Feingold, MD
26 Effect of Pregnancy on Lipid Metabolism and Lipoprotein Levels	Robert Wild, MD, MPH, PhD and Kenneth R. Feingold, MD
TREATMENT
27 Approach to the Patient with Dyslipidemia	Kenneth R. Feingold, MD
28 The Effect of Diet on Cardiovascular Disease and Lipid and Lipoprotein Levels	Kenneth R. Feingold, MD
29 Cholesterol Lowering Drugs	Kenneth R. Feingold, MD
30 Triglyceride Lowering Drugs	Kenneth R. Feingold, MD
31 Lipoprotein Apheresis	Kenneth R. Feingold, MD
PEDIATRIC LIPIDOLOGY
BACKGROUND
32 Is Atherosclerosis a Pediatric Disease	Don P. Wilson, MD, FNLA
33 Fetal and Neonatal Sterol Metabolism	Laura A. Woollett and Amy S. Shah, MD MS, FNLA
34 Non-Invasive Techniques In Pediatric Dyslipidemia	Damon B. Dixon, MD
35 Genetic Testing in Youth – A Primer for Pediatric Lipidologists	Luke Hamilton, MS and Don P. Wilson, MD, FNLA
36 Genetics and Dyslipidemia	Nivedita Patni, MD, Zahid Ahmad, MD and Don P. Wilson, MD, FNLA
SCREENING AND GUIDELINES
37 Guidelines for Screening, Prevention, Diagnosis, and Treatment of Dyslipidemia in Children and Adolescents	Stephen R. Daniels, MD, PhD
38 Lipid Screening in Youth	Justin P. Zachariah MD MPH
39 Understanding Ethical Dilemmas in Pediatric Lipidology- Genetic Testing in Youth	G. Kevin Donovan, MD, MA and Don P. Wilson, MD, FNLA
40 Reproductive Health and Its Impact On Lipid Management in Adolescent and Young Adult Females	Ann Liebeskind, MD, Jennifer Thompson, MD and Don Wilson, MD
HYPERCHOLESTEROLEMIA
41 Familial Hypercholesterolemia	Amy E. Levenson, MD and Sarah D. de Ferranti, MD, MPH
42 Lysosomal Acid Lipase Deficiency	Don P. Wilson, MD, FNLA and Nivedita Patni, MD
43 Sitosterolemia	Ann Liebeskind, MD, Amy L. Peterson, MD, MS and Don P. Wilson, MD, FNLA
44 Cerebrotendinous Xanthomatosis	Nivedita Patni, MD and Don P. Wilson, MD, FNLA
45 Lipoprotein (a) in Youth	Catherine J. McNeal, MD, PhD and Amy L. Peterson, MD, MS
HYPERTRIGLYCERIDEMIA
46 Genetic Disorders Causing Hypertriglyceridemia in Children and Adolescents	Amy S. Shah, MD MS, FNLA and Don P. Wilson, MD, FNLA
47 Secondary Hypertriglyceridemia	Irwin Benuck, MD, PhD, Don P. Wilson, MD, FNLA and Catherine J. McNeal, MD, PhD
48 Combined Dyslipidemia in Children and Adolescents	Rae-Ellen W. Kavey, MD, MPH.
TREATMENT
49 Nutritional Management of Pediatric Dyslipidemia	Lauren A. Williams, MCN, RDN, LD and Don P. Wilson, MD, FNLA
50 Use of Lipid Lowering Medications in Youth	Melissa L Miller, PharmD, Amina Mujkic, PharmD and Chanin C Wright, PharmD.
51 Management of Hospitalized Children with Severe Hypertriglyceridemia	Alejandro De La Torre, MD, Luke Hamilton, MS and Don P. Wilson, MD, FNLA
52 Clinical Management of Dyslipidemia in Youth with Chronic Kidney Disease	Alejandro De La Torre, MD, Nivedita Patni, MD and Don P. Wilson, MD, FNLA
53 The Role Of Parents In The Care Of Children With Dyslipidemia	Gabriella Webster, MS, Melissa Scarcelli, RN, Brenda Sonnier, CCLS, Luke Hamilton, MS and Don P. Wilson, MD, FNLA